Founded by the community for the community, the Ingham Institute’s research focus is linked to the health and medical needs of individuals and families living in South West Sydney.
The Institute works in partnership with the South Western Sydney Local Health District which means that results from the laboratory are transformed into direct health benefits in the form of new treatments and standards of care into the local community.
However, as a charitable organisation, the Institute is reliant on community support to enable our researchers to continue their vital work.
The Ingham Institute was founded with the generosity of two great Australian philanthropists, Bob Ingham AO and Lady Mary Fairfax AC, OBE.
This spirit of corporate philanthropy was demonstrated at the Narellan Rotary Club’s Annual Friends of Rotary Charity Ball earlier this month when more than $1.5 million was donated from leading businesses and developers.
This year saw the Ingham Institute for Applied Medical Research receive donations dedicated to research in bowel cancer, breast cancer, diabetes and robotic surgery training.
“Donations announced on the night were a testament to the benevolent spirit of corporate organisations in South Western Sydney,” Rotary Narellan’s Phil Dowd said.
Demonstrating South West Sydney’s local business corporate philanthropy at its best, The Perich Group donated $150,000 towards the Robotic Surgery Training programs, with an additional $45,000 towards diabetes, bowel and breast cancer research. Breast cancer research was further supported by D.Vitocco Constructions who donated $15,000.
Leading developers demonstrated their investment in both the wellbeing and growth of South West Sydney, with Catherine Park Estate donating $40,000 towards Bowel Cancer research alongside Edgewater Homes, Everyday Homes, Firstyle Homes and Fowler Homes, each contributing $10,000. Diabetes research received $15,000 from Villaworld and $10,000 from Calibre Consulting and the Institute received a further $1 million from the Ingham Family.